• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

1,127
108
74
70
68

COUNTRY

69
22
16
10
9

CATEGORIES

  • 573
  • 119
  • 553
  • 75
  • 528
  • 45
  • 507
  • 18
  • 19
  • 25

PRICE

866
1,155
1,593
2,939

PUBLISHED

33
124
678
2,939

PRODUCT TYPE

2,368
494
67
7
1
1
1

Oncology

The American Cancer Society forecasts that 1,638,910 new cancer cases will occur in the United States in 2012. As cancer rates worldwide are increasing, the oncological sector of the pharmaceutical industry is growing fast and it will continue to provide business opportunities in the next years. However, cancer trials are some of the most complex, time consuming and expensive across all therapeutic areas. What are the new paths to success in this lucrative but challenging market?

Find out the answer in the reports, books, and subscriptions listed under Research and Markets’ Oncology category. Our top-quality publications from industry experts cover every aspect of cancer drug therapy, with a focus on: Lung Cancer, Breast Cancer, Prostate Cancer, Leukaemia, Lymphoma, Ovarian Cancer, Colon Cancer, Cervical Cancer, Brain Cancer and Bladder Cancer. So read on for the latest clinical trials, pipeline reviews, industry news, and commercial opportunities.

Key players featured in our publications include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis, Wyeth, and many more. Show Less
Read more

PRODUCT TITLE

Recurrent Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2014

Recurrent Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Recurrent Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2014’,...

June 2014
FROM

Prostate Cancer - Pipeline Review, H1 2014

Prostate Cancer - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Prostate Cancer - Pipeline Review, H1 2014’, provides an overview of the Prostate Cancer’s therapeutic pipeline. This...

June 2014
FROM

Esophageal Cancer - Pipeline Review, H1 2014

Esophageal Cancer - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Esophageal Cancer - Pipeline Review, H1 2014’, provides an overview of the Esophageal Cancer’s therapeutic pipeline. This...

June 2014
FROM

Chemotherapy Induced Neutropenia - Pipeline Review, H1 2014

Chemotherapy Induced Neutropenia - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Chemotherapy Induced Neutropenia - Pipeline Review, H1 2014’, provides an overview of the Chemotherapy...

June 2014
FROM

Opioid Induced Side Effects - Pipeline Review, H1 2014

Opioid Induced Side Effects - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Opioid Induced Side Effects - Pipeline Review, H1 2014’, provides an overview of the Opioid Induced Side Effects’s...

June 2014
FROM

Thyroid Cancer - Pipeline Review, H1 2014

Thyroid Cancer - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Thyroid Cancer - Pipeline Review, H1 2014’, provides an overview of the Thyroid Cancer’s therapeutic pipeline. This report...

June 2014
FROM

Liposarcoma - Pipeline Review, H1 2014

Liposarcoma - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Liposarcoma - Pipeline Review, H1 2014’, provides an overview of the Liposarcoma’s therapeutic pipeline. This report provides...

June 2014
FROM
Tumor Markers: Unlocking the Mistery of the Genetic Basis of Cancer--Technological Breakthroughs, Emerging Tests, Market Forecasts, Competitive Intelligence Tumor Markers: Unlocking the Mistery of the Genetic Basis of Cancer--Technological Breakthroughs, Emerging Tests, Market Forecasts, Competitive Intelligence - Product Thumbnail Image

Tumor Markers: Unlocking the Mistery of the Genetic Basis of Cancer--Technological Breakthroughs, Emerging Tests, Market Forecasts, Competitive Intelligence

Highlights - Identifies and evaluates major business opportunities emerging in the tumor marker market during the next ten years - Examines trends in the U S , Europe and Japan - Reviews current and...

June 2014
FROM

Basal Cell Carcinoma (Basal Cell Epithelioma) - Pipeline Review, H1 2014

Basal Cell Carcinoma (Basal Cell Epithelioma) - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Basal Cell Carcinoma (Basal Cell Epithelioma) - Pipeline Review, H1 2014’, provides an overview...

June 2014
FROM

Transitional Cell Carcinoma (Urothelial Cell Carcinoma) - Pipeline Review, H1 2014

Transitional Cell Carcinoma (Urothelial Cell Carcinoma) - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Transitional Cell Carcinoma (Urothelial Cell Carcinoma) - Pipeline Review, H1 2014’,...

June 2014
FROM

Hepatic (Liver) Metastasis - Pipeline Review, H1 2014

Hepatic (Liver) Metastasis - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Hepatic (Liver) Metastasis - Pipeline Review, H1 2014’, provides an overview of the Hepatic (Liver) Metastasis’s...

June 2014
FROM

Malignant Glioma - Pipeline Review, H1 2014

Malignant Glioma - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Malignant Glioma - Pipeline Review, H1 2014’, provides an overview of the Malignant Glioma’s therapeutic pipeline. This...

June 2014
FROM

Chemotherapy Induced Nausea and Vomiting - Pipeline Review, H1 2014

Chemotherapy Induced Nausea and Vomiting - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Chemotherapy Induced Nausea and Vomiting - Pipeline Review, H1 2014’, provides an overview of...

June 2014
FROM

Adenocarcinoma Of The Gastroesophageal Junction - Pipeline Review, H1 2014

Adenocarcinoma Of The Gastroesophageal Junction - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Adenocarcinoma Of The Gastroesophageal Junction - Pipeline Review, H1 2014’, provides an...

June 2014
FROM

Rhabdomyosarcoma - Pipeline Review, H1 2014

Rhabdomyosarcoma - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Rhabdomyosarcoma - Pipeline Review, H1 2014’, provides an overview of the Rhabdomyosarcoma’s therapeutic pipeline. This...

June 2014
FROM

Chemotherapy Induced Peripheral Neuropathy - Pipeline Review, H1 2014

Chemotherapy Induced Peripheral Neuropathy - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Chemotherapy Induced Peripheral Neuropathy - Pipeline Review, H1 2014’, provides an overview...

June 2014
FROM

High-Grade Glioma - Pipeline Review, H1 2014

High-Grade Glioma - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘High-Grade Glioma - Pipeline Review, H1 2014’, provides an overview of the High-Grade Glioma’s therapeutic pipeline. This...

June 2014
FROM

Nonmelanomatous Skin Cancer - Pipeline Review, H1 2014

Nonmelanomatous Skin Cancer - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Nonmelanomatous Skin Cancer - Pipeline Review, H1 2014’, provides an overview of the Nonmelanomatous Skin Cancer’s...

June 2014
FROM

Bladder Carcinoma - Pipeline Review, H1 2014

Bladder Carcinoma - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Bladder Carcinoma - Pipeline Review, H1 2014’, provides an overview of the Bladder Carcinoma’s therapeutic pipeline. This...

June 2014
FROM

Gastroesophageal (GE) Junction Carcinomas - Pipeline Review, H1 2014

Gastroesophageal (GE) Junction Carcinomas - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Gastroesophageal (GE) Junction Carcinomas - Pipeline Review, H1 2014’, provides an overview of...

June 2014
FROM
Loading Indicator

Our Clients

Our clients' logos